THE ALBUMIN IN ACUTE STROKE (ALIAS) MULTICENTER CLINICAL TRIAL: SAFETY ANALYSIS OF PART 1, AND RATIONALE AND DESIGN OF PART 2

BACKGROUND AND PURPOSE: Enrollment in the ALIAS Trial was suspended in late 2007 due to a safety concern. Here we present the safety data of that Trial (“Part 1”) and the rationale for the design of Part 2. METHODS: ALIAS Part 1 was designed to assess whether 25% albumin (ALB) begun within 5h of str...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ginsberg, Myron D., Palesch, Yuko Y., Martin, Renee H., Hill, Michael D., Moy, Claudia S., Waldman, Bonnie D., Yeatts, Sharon D., Tamariz, Diego, Ryckborst, Karla
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3076742/
https://ncbi.nlm.nih.gov/pubmed/21164127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.110.596072
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires